Author:
Burlacu Alexandru,Covic Adrian
Publisher
Springer International Publishing
Reference219 articles.
1. Esler M, Kaye D. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure. J Auton Nerv Syst. 1998;72(2–3):210–9.
2. Ozel E, Tastan A, Ozturk A, Ozcan EE. Relationship between sympathetic Overactivity and left ventricular hypertrophy in resistant hypertension. Hellenic J Cardiol HJC Hellenike Kardiologike Epitheorese. 2015;56(6):501–6.
3. Tsioufis C, Kordalis A, Flessas D, Anastasopoulos I, Tsiachris D, Papademetriou V, et al. Pathophysiology of resistant hypertension: the role of sympathetic nervous system. Int J Hypertens. 2011;2011:642416.
4. Seravalle G, Dimitriadis K, Dell’Oro R, Grassi G. How to assess sympathetic nervous system activity in clinical practice. Curr Clin Pharmacol. 2013;8(3):182–8.
5. O’Callaghan EL, McBryde FD, Burchell AE, Ratcliffe LE, Nicolae L, Gillbe I, et al. Deep brain stimulation for the treatment of resistant hypertension. Curr Hypertens Rep. 2014;16(11):493.